Login / Signup

Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic.

Rontgene SolanteCarlos Alvarez-MorenoErlina BurhanSuwat ChariyalertsakNan-Chang ChiuSunate ChuenkitmongkolD V DungKao-Pin HwangJavier Ortiz IbarraSasisopin KiertiburanakulPrasad S KulkarniChristopher LeePing-Ing LeeRommel Crisenio LoboAlejandro MaciasCao Huu NghiaAnna Lisa T Ong-LimAlfonso Javier Rodriguez-MoralesRosana RichtmannMarco Aurélio Palazzi SafádiHindra Irawan SatariGuy Thwaites
Published in: Expert review of vaccines (2022)
Booster shots of the current COVID-19 vaccines provide consistently high protection against Omicron-related severe disease and death. Additionally, this protection appears to be conserved for at least 3 months, with a small but significant waning after that. The positive risk-benefit ratio of these vaccines is well established, giving us confidence to administer additional doses as required. Future vaccination strategies will likely include a combination of schedules based on risk profile, as overly frequent boosting may be neither beneficial nor sustainable for the general population.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • early onset
  • clinical practice
  • machine learning